[an error occurred while processing this directive] | [an error occurred while processing this directive]
Influencing factors of dose coverage of unplanned irradiation of internal mammary lymph node drainage area in patients receiving radiotherapy after mastectomy
Wang Wei,Meng Yingtao,Sun Tao,Song Yuanfang,Xu Min,Shao Qian,Zhang Yingjie,Yu Ting,Li Jianbin
Department of Radiation Oncology (Wang W,Meng YT,Song YF,Xu M,Shao Q,Zhang YJ,Yu T,Li JB),Department of Medical Physics (Sun T),Shandong Cancer Hospital Affiliated to Shandong University,Ji′nan 250117,China
Abstract Objective To investigate the influencing factors of the dose coverage of unplanned internal mammary lymph node (IMN) irradiation in patients receiving chemotherapy after mastectomy. Methods Clinical data of 138 patients receiving radiotherapy in the upper and lower lymph node drainage area of the thoracic wall and clavicle [three-dimensional conformal radiotherapy (3DCRT),field-in-field forward intensity-modulated radiotherapy (F-IMRT) or inverse IMRT (I-IMRT)] were retrospectively analyzed. The IMN was delineated according to the Radiation Therapy Oncology Group (RTOG) criteria. The unplanned irradiation dose of the IMN was obtained. The correlation between the IMN irradiation dose,clinical characteristics and specific parameters of radiotherapy during the unplanned irradiation was statistically analysed. Results The mean dose of unplanned IMN irradiation was 32.85 Gy (range:2.76-50.93 Gy).In total,7.3% of breast cancer patients obtained the therapeutic dose of≥ 45 Gy. Body weight,body mass index (BMI),body surface area (BSA) and thoracic transverse diameter (DT) were lower,whereas the planning target volume of IMN (VIMN) included in the chest wall PTV (IMNin) and the ratio of IMNin to VIMN were higher compared with those of their counterparts with insufficient therapeutic dose. Multivariate regression analysis demonstrated that body weight,thoracic anteroposterior diameter (DAP),DT,RIMNin and PTV volume were the influencing factors of the dose coverage of unplanned IMN irradiation (P=0.000,0.000,0.001,0.000 and 0.034). Conclusions For patients receiving chemotherapy after mastectomy,the dose coverage significantly varies when the IMN is the unplanned target. Partial patients achieve the therapeutic dose. The dose coverage of unplanned IMN irradiation is influenced by physical characteristics,anatomical features and technical parameters of radiotherapy,which should be emphasized during the study design and result analysis.
Corresponding Authors:
Li Jianbin,Email:lijianbin@msn.com
Cite this article:
Wang Wei,Meng Yingtao,Sun Tao et al. Influencing factors of dose coverage of unplanned irradiation of internal mammary lymph node drainage area in patients receiving radiotherapy after mastectomy[J]. Chinese Journal of Radiation Oncology, 2018, 27(8): 744-748.
Wang Wei,Meng Yingtao,Sun Tao et al. Influencing factors of dose coverage of unplanned irradiation of internal mammary lymph node drainage area in patients receiving radiotherapy after mastectomy[J]. Chinese Journal of Radiation Oncology, 2018, 27(8): 744-748.
[1] Recht A,Edge SB,Solin LJ,et al. Postmastectomy radiotherapy:clinical practice guidelines of the American Society of Clinical Oncology[J].J Clin Oncol,2001,19(5):1539-1569.DOI:10.1200/JCO.2001.19.5.1539. [2] McGale P,Taylor C,Correa C,et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality:meta-analysis of individual patient data for 8135 women in 22 randomised trials[J].Lancet,2014,383(9935):2127-2135.DOI:10.1016/S0140-6736(14)60488-8. [3] Recht A,Comen EA,Fine RE et al. Postmastectomy Radiotherapy:an American Society of Clinical Oncology,American Society for Radiation Oncology,and society of surgical oncology focused guideline update[J].J Clin Oncol,2016,34(36):4431-4442.DOI:10.1200/JCO.2016.69.1188. [4] Moreno AC,Shaitelman SF,Buchholz TA.A clinical perspective on regional nodal irradiation for breast cancer[J].Breast,2017,34(1):S85-S90.DOI:10.1016/j.breast.2017.06.035. [5] Whelan TJ,Olivotto IA,Parulekar WR,et al,MA.20 Study Investigators. Regional nodal irradiation in early-stage breast cancer[J]. N Engl J Med,2015,373(4):307-316.DOI:10.1056/NEJMoa1415340. [6] Matzinger O,Heimsoth I,Poortmans P,et al. EORTC Radiation Oncology & Breast Cancer Groups. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage Ⅰ to Ⅲ breast cancer(EORTC trial22922/10925)[J].Acta Oncol,2010,49(1):24-34.DOI:10.3109/02841860903352959. [7] Thorsen LB,Offersen BV,Dan H,et al. DBCG-IMN:A population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer[J].J Clin Oncol,2016,34(4):314-320.DOI:10.1200/JCO.2015.63.6456. [8] Grellier-Adedjouma N,Chevrier M,Fourquet A,et al. Long-term results of a highly performing conformal electron therapy technique for chest wall irradiation after mastectomy[J].Int J Radiat Oncol Biol Phys,2017,98(1):206-214.DOI:10.1016/j.ijrobp.2017.01.205. [9] Dess RT,Liss AL,Griffith KA,et al. Ischemic cardiac events following treatment of internal mammary nodal region using contemporary radiation planning techniques[J].Int J Radiat Oncol Biol Phys,2017,99(5):1146-1153.DOI:10.1016/j.ijrobp.2017.06.2459. [10] Taylor CW,Wang Z,Macaulay E,et al. Exposure of the heart in breast cancer radiation therapy:a systematic review of heart doses published during 2003 to 2013[J].Int J Radiat Oncol Biol Phys,2015,93(4):845-853.DOI:10.1016/j.ijrobp.2015.07.2292. [11] Xie L,Higginson DS,Marks LB.Elective regional nodal irradiation in patients with early-stage breast cancer[J].Semin Radiat Oncol,2011,21(1):66-78.DOI:10.1016/j.semradonc.2010.08.006. [12] Poortmans PM,Collette S,Kirkove C,et al. EORTC Radiation OncologyandBreastCancerGroups. Internal mammary and medial supraclavicular irradiation in breast cancer[J].N Engl J Med,2015,373(4):317-327.DOI:10.1056/NEJMoa1415369. [13] Sapienza LG,Chen MJ,Gomes MJ,et al. Unintended irradiation of internal mammary chain-Is that enough?[J].Rep Pract Oncol Radiother,2016,21(1):25-30.DOI:10.1016/j.rpor.2015.07.006. [14] Arora D,Frakes J,Scott J,et al. Incidental radiation to uninvolved internal mammary lymph nodes in breast cancer[J].Breast Cancer Res Treat,2015,151(2):365-372.DOI:10.1007/s10549-015-3400-9. [15] Chung Y,Kim JW,Shin KH,et al. Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients:Korean Radiation Oncology Group 08-06 study[J].Int J Radiat Oncol Biol Phys,2015,91(2):419-426.DOI:10.1016/j.ijrobp.2014.10.022. [16] Leite ET,Ugino RT,Santana MA,et al. Incidental irradiation of internal mammary lymph nodes in breast cancer:conventional two-dimensional radiotherapy versus conformal three-dimensional radiotherapy[J].Radiol Bras,2016,49(3):170-175.DOI:10.1590/0100-3984.2015.0003. [17] Kanyilmaz G,Aktan M,Koc M,et al. Unplanned irradiation of internal mammary lymph nodes in breast cancer[J].Radiol Med,2017,122(6):405-411.DOI:10.1007/s11547-017-0747-5. [18] Giuliano AE,McCall L,Beitsch P,et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissectionin patients with sentinel lymph node metastases:the American College of Surgeons Oncology Group Z0011 randomized trial[J].Ann Surg,2010,252(3):426-432.DOI:10.1097/SLA.0b013e3181f08f32. [19] Krag DN,Anderson SJ,Julian TB,et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer:overall survival findings from the NSABP B-32 randomised phase 3 trial[J].Lancet Oncol,2010,11(10):927-933.DOI:10.1016/S1470-2045(10)70207-2. [20] 王玮,孟英涛,宋远芳,等.乳腺癌改良根治术后不同计划方式下内乳淋巴引流区非计划照射受照剂量比较研究[J].中华肿瘤学杂志,2018,待发表. Wang W,Meng YT,Song YF,et al. Comparation study of incidental irradiation dose to the internal mammary chain during postmastectomy radiotherapy for patients with different irradiation techniques. Chin J Oncol,2018,In press. [21] 宋远芳,王玮,李建彬,等.保乳术后逆向调强、正向调强和三维适形计划下内乳区非计划性受照剂量的比较研究[J].中华放射肿瘤学杂志,2018,27(1):63-67.DOI:10.3760/cma.j.issn.1004-4221.2018.01.015. Song YF,Wang W,Li JB,et al. Comparison of incidental irradiation dose to the internal mammary nodes among I-IMRT,F-IMRT,and 3DCRT after breast-conserving surgery[J].Chin J Radiati Oncol,2018,27(1):63-67.DOI:10.3760/cma.j.issn.1004-4221.2018.01.015. [22] Hare GB,Proulx GM,Lamonica DM,et al. Internal mammary lymph node (IMN) coverage by standard radiation tangent fields in patients showing IMN drainage on lymphoscintigraphy:therapeutic implications[J].Am J Clin Oncol,2004,27(3):274-278. [23] Proulx GM,Lee RJ,Stomper PC.Internal mammary lymph node inclusion in standard tangent breast fields:effects of body habitus[J].Breast J,2001,7:111-116. [24] Barry A,Rock K,Sole C,et al. The impact of active breathing control on internal mammary lymph node coverage and normal tissue exposure in breast cancer patients planned for left-sided postmastectomy radiation therapy[J].Pract Radiat Oncol,2017,7(4):228-33.DOI:10.1016/j.prro.2016.11.010. [25] Aguiar A,Gomes Pereira H,Azevedo I,Gomes L.Evaluation of axillary dose coverage following whole breast radiotherapy:variation with the breast volume and shape[J].Radiother Oncol,2015,114(1):22-7.DOI:10.1016/j.radonc.2014.10.005.
2018, Vol. 27 
